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Abstract
Background Comparative effectiveness research in spine
surgery is still a rarity. In this study, pain alleviation and
quality of life (QoL) improvement after lumbar total disc
arthroplasty (TDA) and anterior lumbar interbody fusion
(ALIF) were anonymously compared by surgeon and implant.
Methods A total of 534 monosegmental TDAs from
the SWISSspine registry were analyzed. Mean age was
42 years (19–65 years), 59 % were females. Fifty cases
with ALIF were documented in the international Spine
Tango registry and used as concurrent comparator group for
the pain analysis. Mean age was 46 years (21–69 years), 78
% were females. The average follow-up time in both sam-
ples was 1 year. Comparison of back/leg pain alleviation
and QoL improvement was performed. Unadjusted and
adjusted probabilities for achievement of minimum clini-
cally relevant improvements of 18 VAS points or 0.25
EQ-5D points were calculated for each surgeon.
Results Mean preoperative back pain decreased from 69
to 30 points at 1 year (ØD 39pts) after TDA, and from 66 to
27 points after ALIF (ØD 39pts). Mean preoperative QoL
improved from 0.34 to 0.74 points at 1 year (ØD 0.40pts).
There were surgeons with better patient selection, indicated
by lower adjusted probabilities reflecting worsening of
outcomes if they had treated an average patient sample.
ALIF had similar pain alleviation than TDA.
Conclusions Pain alleviation after TDA and ALIF was
similar. Differences in surgeon’s patient selection based on
pain and QoL were revealed. Some surgeons seem to miss
the full therapeutic potential of TDA by selecting patients
with lower symptom severity.
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Abbreviations
ALIF Anterior lumbar interbody fusion
COMI Core outcome measures index
EQ-5D EuroQoL-5D instrument
MCRIQL Minimum clinically relevant improvement of
quality of life = 0.25 EQ-5D points [2]
MCRPI Minimum clinically relevant pain
improvement = 18 VAS points [10]
NASS North American Spine Society outcome
assessment instrument
QoL Quality of life
TDA Total disc arthroplasty
VAS Visual analogue scale
Introduction
In 2010, the Obama administration provided 1.1 billion
USD for so-called comparative effectiveness research.
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Besides comparison of different therapies, comparison of
implants and even of health care providers is possible.
‘‘Treatment success’’, enabling comparison of more or less
effective therapies, may be influenced by a multitude of
factors and is rarely clearly defined. A minimum clinically
relevant improvement of a certain symptom could be used
for its definition, but also the average improvement of the
same symptom within a group of implants or physicians, a
value referred to as ‘‘benchmark’’.
Recently, the possibility of benchmarking between sin-
gle lumbar disc prosthesis against the pool of all other
prostheses was shown in the SWISSspine registry [1–3].
The example of this governmentally mandated registry
with its uniform documentation opens benchmarking pos-
sibilities between implants and surgeons, but the lack of an
included comparator like anterior lumbar interbody fusion
(ALIF), hampers conclusions about general superiority or
inferiority of lumbar TDA. Therefore, we drew information
from the international Spine Tango registry for enabling
comparative effectiveness research between lumbar TDAs,
ALIF and the healthcare providers.
The current study therefore anonymously compared back
and leg pain alleviation after total disc arthroplasty and
ALIF stratified by implant and surgeon from the SWISS-
spine and Spine Tango registries. We hypothesized that
TDA was not inferior to ALIF regarding back and leg pain
alleviation and that there were significant differences in
outcomes of pain alleviation and quality of life improvement
between the best and the worst performing TDA surgeons.
Materials and methods
SWISSspine registry
The structure and setup of the registry was described
elsewhere [1, 2]. Currently, 49 surgeons from 32 hospitals
are contributing data since 2005. In November 2010, there
were data on 534 monosegmental TDAs with a preopera-
tive and at least one post-operative NASS and EQ-5D
questionnaire available from 313 females (59 %) and 221
males (41 %). Mean age was 42 years (range 19–65 years).
From the eight different disc prosthesis models, four had
at least ten documented cases. They contributed a total of
521 cases (on average *130 cases per prosthesis, range
37–247). Thirteen remaining cases had disc prostheses
from other suppliers and were grouped for further com-
parisons (‘‘other TDA prostheses’’).
For synchronization of follow-up times, the last avail-
able follow-up per patient until the end of the second post-
operative year was used for statistical assessment. The
average follow-up time in this SWISSspine sample was
1 year.
Fifteen of 49 surgeons had 10 documented cases or more
each. These 15 surgeons covered 418 cases (average 27
cases per surgeon, range 10–76). The remaining 116
patients treated by the remaining 34 surgeons (average 3
cases per surgeon, range 1–9) were grouped for further
comparisons (‘‘other’’ surgeons).
The 15 individual surgeons and the group of 34 ‘‘other’’
surgeons on the one hand and 4 implant suppliers and the
group of ‘‘other TDA prostheses’’ on the other hand were
compared in an anonymised way regarding patient back
and leg pain alleviation and quality of life improvement.
Spine Tango registry
The registry of the Spine Society of Europe allows docu-
mentation of different spinal surgical and conservative
procedures [4–7] and has currently a case load of over
40,000 surgeries. Being a non-mandatory registry, the users
are asked to document primary and follow-up surgeon-
based forms and at least one pre- and post-operative
patient-based COMI form [8].
Comparator group from Spine Tango
The fusion of affected lumbar segments in surgical candi-
dates with chronic low back pain has been the standard
surgical procedure for almost 50 years and remains the
gold standard until today [9]. The inclusion criteria for the
treatment reference group (ALIF) were the following:
monosegmental procedure ? linkage to at least one com-
pleted preoperative and one post-operative COMI form ?
lumbar/lumbo-sacral level of procedure ? degenerative
disease as main diagnosis ? no previous surgery on the
same level ? retroperitoneal/transperitoneal approach ?
anterior fusion between adjacent vertebral bodies ? rigid
stabilization using a cage. The query resulted in 50 single
patients from 3 surgeons (average 16 cases per surgeon,
range 12–22). The female/male ratio was 39/11. Mean age
was 46 years (range 21–69 years). The last available
follow-up per patient within 2.5 years was used for the
statistical assessment. The average follow-up time in the
sample was 1 year. The 50 selected patients had no doc-
umented EQ-5D forms and the comparison between TDA
(SWISSspine) and ALIF (Spine Tango) was therefore
limited to post-operative pain alleviation.
Statistical analysis
We compared probabilities for achievement of minimum
clinically relevant pain (MCRPI) and quality of life
(MCRIQL) improvement of 18 VAS points [10] and of
0.25 EQ-5D points [2]. Preoperative pain levels influence
post-operative pain alleviation and similarly, preoperative
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quality of life influences its post-operative improvement [1,
2]. Further analyzed co-variates, such as implant, surgeon,
depression, age, gender, follow-up interval and length of
hospitalization had no significant influence on pain allevi-
ation. Therefore, in a first step a univariate logistic
regression (MRCPI or MCRIQL vs. implant or vs. surgeon)
resulting in non-adjusted probabilities and, in a second
step, a generalized linear model (MRCPI or MCRIQL vs.
implant or vs. surgeon) adjusted by preoperative pain level
or quality of life were calculated.
For within-group comparisons, Wilcoxon signed-rank or
Chi-square test was used. For between-group comparisons,
Wilcoxon rank-sum test was used. a was set to 0.05. All
statistical analyses were conducted using SAS 9.2 (SAS
Institute Inc, USA).
Results
Comparison of both samples only showed significant dif-
ferences regarding patient age and gender. ALIF patients
were on average 4 years older and there were 19 % more
females. Pre-operative and post-operative pain values as
well as pre- to post-operative changes were not signifi-
cantly different between the samples.
TDA outcomes
Mean preoperative back pain on VAS was 69 points and
leg pain was 54 points and mean post-operative back pain
was 30 points and leg pain was 23 points (pre- to post-op,
both p \ 0.001). Hence, there was a back pain alleviation
of 39 points and leg pain alleviation of 31 points at the last
available follow-up. Mean preoperative quality of life was
0.34 points on EQ-5D and improved to 0.74 points at the
last follow-up (pre- to post-op p \ 0.001). The improve-
ment was equal to 0.4 points.
ALIF outcomes
Mean preoperative back pain on VAS was 66 points and
leg pain was 49 points and mean post-operative back and
leg pain were 27 and 22 points, respectively (pre- to post-
op, both p \ 0.001). Back pain alleviation of 39 points and
leg pain alleviation of 27 points were observed.
Stratification by supplier
Figures 1 and 2 show similar average and median values
for the post-operative back and leg pain alleviation
stratified by disc prosthesis model in the SWISSspine
and Spine Tango groups. The difference between the best
and the worst average back pain alleviation was only 9
VAS points (Fig. 1). The variation of leg pain alleviation
between major disc models was relatively low, though
the grouped ‘‘other TDA prostheses’’ were better than
ALIF by an average of 15 VAS (n.s.) (Fig. 2). For all
four major prosthesis suppliers in SWISSspine as well
as for ALIF in Spine Tango, the post-operative pain
alleviation was approximately twice the MCRPI for
back pain and slightly less than twice the MCRPI for leg
pain.
Fig. 1 Back pain alleviation
after TDA (green) and after
ALIF (reference, blue) by
supplier. The upper reference
line represents the average post-
operative back pain alleviation
of 39 points. The lower
reference line represents the 18
VAS points regarded as
minimum clinically relevant
pain improvement. The
increased adjusted probabilities
are marked in grey
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Unadjusted and adjusted probabilities
If a prosthesis model gains probabilities of providing the
MCRIP after adjustment for preoperative pain or quality of
life, then the surgeons have implanted it into patients with
lower preoperative pain or higher quality of life levels than
the average, the benchmark. This is the case for three
prosthesis models and the ALIF group (Fig. 1). If pros-
thesis loses probabilities for providing minimum clinically
relevant pain alleviation after adjustment, the surgeons
using it have applied stricter inclusion criteria than the
benchmark in terms of preoperative pain or quality of life.
This is also reflected by the proportion of cases with pre-
operative back pain levels above a previously revealed
threshold level of 43.8 points on VAS [2] which is higher
in the relatively more successful prosthesis models, or by
the higher proportion of patients with preoperative back
pain levels below the benchmark of 69 VAS points in the
relatively less successful models. All prosthesis models
with theoretical outcome improvement after adjustment are
highlighted in grey.
There is a similar picture for leg pain, except for the
ALIF comparator group performing slightly worse
regarding leg pain alleviation. Given the non-significant
and clinically irrelevant differences, and considering the
fact that patients were on average 4 years older, which the
model was not adjusted for, the ALIF performance is well
comparable with that of TDA (Fig. 2).
Regarding improvement of quality of life, the four
supplier’s products were similar in their outcomes and the
grouped other prostheses were even slightly better (Fig. 3).
The difference between the worst and best average
improvement of quality of life was 0.16 points (n.s.). Once
again, three prosthesis models had better adjusted proba-
bilities, i.e. their outcomes could have theoretically been
better had all their patients had at least the average pre-
operative quality of life of 0.342 points EQ-5D or less.
Stratification by surgeon
The stratification of back and leg pain alleviation by sur-
geon showed more variation in outcomes (Figs. 4, 5). With
one exception, the average back pain alleviation of all
surgeons was above the MCRPI of 18 VAS points. For leg
pain alleviation, there were 2 TDA and 1 ALIF surgeons
below the MCRPI. There are surgeons with a superior
performance showing more than 75 % of the patients with
achieved MCRPI (Fig. 4, lower reference line) and some
do even show outcomes where around 75 % of the patients
have an over-average post-operative back pain alleviation
(Fig. 4, upper reference line).
There were seven surgeons (1 ALIF) who strictly
selected patients regarding preoperative back pain and
eight surgeons (1 ALIF) who selected patients similarly
strict regarding leg pain. This is indicated by the lower
adjusted than the non-adjusted probabilities reflecting
worsening of patient outcome if an average patient would
have been treated. Other surgeons had higher adjusted
probabilities indicative of lower preoperative pain values in
their patient sample compared with an average patient pain
level (Figs. 4, 5).
Further to the right on Fig. 4, more patients with a
minimum preoperative back pain level of at least 43.8 VAS
points (acc. to the recommended threshold [2]) can be
Fig. 2 Leg pain alleviation
after TDA (green) and after
ALIF (reference, blue) by
supplier. The upper reference
line represents the average post-
operative back pain alleviation
of 31 points. The lower
reference line represents the 18
VAS points regarded as
minimum clinically relevant
pain improvement. The
increased adjusted probabilities
are marked in grey
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observed (table in Fig. 4). Similarly, towards the right,
fewer patients under the average preoperative back pain
level of 69 VAS points were observed (table in Fig. 4).
Post-operative improvement of quality of life also had
more variation than stratification by supplier (Fig. 6). Ten
out of 16 surgeons had higher adjusted probabilities
reflecting an existing potential for further post-operative
increase of quality of life (Fig. 6). Surgeon 2 for example
had almost 77 % of the patients with preoperative quality
of life above the average in the registry and the probability
of achieving a MCRIQL of 0.25 points on EQ-5D was only
29 %. For an average patient in the pool, a 48 % probability
may be expected. The surgeon with the best patient
selection for this outcome was number 16, who had only 6
% of the patients above the preoperative average quality of
life and a 82 % non-adjusted and a 52 % adjusted proba-
bility for reaching the MCRIQL.
Discussion
Our first hypothesis was confirmed in that some TDA
implant types had a slightly better back pain alleviation,
some were slightly worse than with ALIF. Regarding leg
pain relief, all TDA prostheses achieved slightly higher
values. None of the differences were significant and the
Fig. 3 Improvement of quality
of life after TDA by supplier.
The upper reference line
represents the average
improvement of quality of life
of 0.396 EQ-5D points. The
lower reference line represents
the 0.25 points regarded as
minimum clinically relevant
quality of life improvement.
The increased adjusted
probabilities, which means
better outcome if the disc
implant would be implanted in
an average patient, are marked
in grey
Fig. 4 Back pain alleviation
after TDA (green) and after
ALIF (comparator, blue) by
different surgeons. The upper
reference line represents the
average post-operative back
pain alleviation of 39 points.
The lower reference line
represents the 18 VAS points
regarded as minimum clinically
relevant pain improvement. The
thicknesses of box plots vary
proportionally to the respective
subgroup size. The increased
adjusted probabilities are
marked in grey
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ALIF sample was 4 years older. The TDA outcomes, pain
relief and quality of life improvement within a sample of
skilled and certified spine surgeons were not significantly
different and we had to consequently reject our second
hypothesis, but average differences in pre- to post-opera-
tive pain levels and EQ-5D scores were sufficiently large to
be regarded as clinically relevant.
Total disc arthroplasty being a relatively new treatment
method has gained wide use in developed countries.
Comparisons of different disc implants in the literature are
largely missing as practically all previous studies on total
disc arthroplasty report on only one implant or compare
two implants regarding one specific issue. The study
designs of these investigations are frequently quite differ-
ent, resulting in difficult and inaccurate comparisons.
Collection of nationwide data on disc arthroplasty and
use of standard documentation instruments allowed for
reasonable comparisons between different implants and
surgeons.
According to the published earlier results, the major
implants did not have any significant influence on post-
operative functional outcome [2]. Our comparative effec-
tiveness analysis showed that the four most frequently used
prosthesis models provide good post-operative back and
Fig. 5 Leg pain alleviation
after TDA (green) and after
ALIF (comparator, blue) by
different surgeons. The upper
reference line represents the
average post-operative leg pain
alleviation of 31 points. The
lower reference line represents
the 18 VAS points regarded as
minimum clinically relevant
pain improvement. The
thicknesses of box plots vary
proportionally to the respective
group size. The increased
adjusted probabilities are
marked in grey
Fig. 6 Improvement of quality
of life after TDA by different
surgeons. The upper reference
line represents the average
improvement of quality of life
of 0.396 EQ-5D points. The
lower reference line represents
the 0.25 points regarded as
minimum clinically relevant
quality of life improvement.
The thicknesses of box plots
vary proportionally to the
respective group size. The
increased adjusted probabilities
are marked in grey
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leg pain alleviation and similar improvement of quality of
life. Presented results support our assumption that the post-
operative outcome differences rather lie in other factors,
such as the surgeon and his patient selection.
Our recent study revealed probable differences in patient
selection resulting in outcome variations [3]. These dif-
ferences were confirmed in the present study. There was
considerable variation of the results when stratified by
surgeon. According to common knowledge treatment out-
come is influenced by its respective preoperative status [1,
2]. Some surgeons seem to miss the full pain alleviation
and quality of life improvement potential by selection of
patients with rather low preoperative pain levels and a
rather good preoperative quality of life.
A major drawback of the SWISSspine registry is the
absence of a comparator for lumbar TDA which could e.g.
be ALIF. Therefore, we used ALIF data from the interna-
tional spine registry Spine Tango [4–6, 11]. Our results
showed that ALIF patients had the same back pain allevi-
ation as TDA patients. Also, leg pain alleviation after ALIF
was not significantly different from that after TDA, though
ALIF patients had generally slightly lower preoperative
pain levels. Stratification by surgeon also showed variation
of pain alleviation in ALIF surgeons. Two of the three
ALIF surgeons apparently also miss the full potential of
pain alleviation and quality of life increase by selection of
patients with low preoperative pain levels.
The above observations underline the importance of
making a good indication for surgery. Within the multi-
tude of predictors we could assess, only the preoperative
levels of back pain, leg pain and quality of life were
influencing their post-operative outcomes. Patient demo-
graphic factors, comorbidities or number of treated levels
all had insignificant effects. The most successful surgeons
were those with very strict selection criteria reflected by
high preoperative pain levels and low quality of life. In a
situation where alternative treatments like ALIF or even
an intensive rehabilitation programme, possibly combined
with cognitive behavioural therapy, exist, the question
must be asked if a new therapy with still unknown long-
term outcomes and risks as well as clinically unproven
theoretical advantages like the prevention of adjacent
segment disease must not be applied more carefully and
selectively. Regulating the application of a therapy with
strict inclusion criteria or monitoring its use and related
outcomes are viable options. Measuring, e.g. in the
framework of a nationwide registry does probably have
advantages like quality control and additional evidence
generation for these new treatments or their alternatives.
In any case, a first step towards improvement of outcome
quality could be education about making indications by
the best performers. If low outcome quality persists in
poorer performing centres, further measures do of course
need to be discussed, but will probably largely depend on
frameworks of the respective healthcare systems.
Limitations
We studied three major influential factors (surgeon,
implant, procedure), thereby adjusting for those co-variates
that were available in the registry. Patients from mandatory
and voluntary registers may have different characteristics
that cannot completely be controlled with the registry data
set. In the current study only age and sex were significantly
different, which is, however, rather attributable to the
intervention than to the registry setting. Other co-variates
with influence on post-operative pain levels and quality of
life may also exist. Furthermore, a clear domination of both
types of pain may not always be given. Some patients may
be treated for high preoperative back pain levels with low
or no preoperative leg pain, which may have led to good
probabilities for back pain MCRPI but low ones for leg
pain. In non-anonymised comparisons, such added com-
plexities must be considered.
Finally, the study was based on 1-year follow-ups only.
Although longer follow-ups would be desirable, there is
evidence that the results of spinal surgery are often quasi
final from the 3-month follow-up onwards [8].
Conclusions
Remarkable variations of pain alleviation by different
surgeons were observed. Statistical analysis confirmed
selection or indication criteria as at least one of the causes.
Although influence of surgeon or implant on pain allevia-
tion after total disc arthroplasty is not significant based on
the presented data, it may be clinically relevant. The only
significantly influencing co-variate remains the preopera-
tive pain level.
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